Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Fenoglio

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Cellular and Molecular Life Sciences : CMLS|August 26, 2025
Immunoregulatory properties of cell free DNAFrancesca Ferrera, Tiziana Altosole, Samuele Tardito, et al.
STAR Protocols|December 20, 2024
Protocol for flow cytometry immunophenotyping of human antigen-specific T cells by activation-induced marker and Th1 cytokine detectionGianluca Rotta, Valentina Achille, Scott J Bornheimer, et al.
Plos Pathogens|April 16, 2021
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severityFederica Bozzano, Chiara Dentone, Carola Perrone, et al.
Cancers|June 2, 2021
Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck CancerDaniela Fenoglio, Liliana Belgioia, Alessia Parodi, et al.
Vaccines|November 11, 2022
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 VaccinationChiara Dentone, Daniela Fenoglio, Marta Ponzano, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2021
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trialGilberto Filaci, Daniela Fenoglio, Franco Nolè, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 19, 2023
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cellsAdriana Amaro, Francesco Reggiani, Daniela Fenoglio, et al.
Open Forum Infectious Diseases|November 19, 2021
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case StudyChiara Sepulcri, Chiara Dentone, Malgorzata Mikulska, et al.
Journal of the International AIDS Society|November 15, 2014
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mLChiara Dentone, Daniela Fenoglio, Alessio Signori, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2017
CD8<sup>+</sup>CD28<sup>-</sup>CD127<sup>lo</sup>CD39<sup>+</sup> regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?Daniela Fenoglio, Chiara Dentone, Alessio Signori, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Cellular and Molecular Life Sciences : CMLS|August 26, 2025
Immunoregulatory properties of cell free DNAFrancesca Ferrera, Tiziana Altosole, Samuele Tardito, et al.
STAR Protocols|December 20, 2024
Protocol for flow cytometry immunophenotyping of human antigen-specific T cells by activation-induced marker and Th1 cytokine detectionGianluca Rotta, Valentina Achille, Scott J Bornheimer, et al.
Plos Pathogens|April 16, 2021
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severityFederica Bozzano, Chiara Dentone, Carola Perrone, et al.
Cancers|June 2, 2021
Development of Exhaustion and Acquisition of Regulatory Function by Infiltrating CD8+CD28- T Lymphocytes Dictate Clinical Outcome in Head and Neck CancerDaniela Fenoglio, Liliana Belgioia, Alessia Parodi, et al.
Vaccines|November 11, 2022
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 VaccinationChiara Dentone, Daniela Fenoglio, Marta Ponzano, et al.
Cancer Immunology, Immunotherapy : CII|August 5, 2021
Telomerase-based GX301 cancer vaccine in patients with metastatic castration-resistant prostate cancer: a randomized phase II trialGilberto Filaci, Daniela Fenoglio, Franco Nolè, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 19, 2023
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cellsAdriana Amaro, Francesco Reggiani, Daniela Fenoglio, et al.
Open Forum Infectious Diseases|November 19, 2021
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case StudyChiara Sepulcri, Chiara Dentone, Malgorzata Mikulska, et al.
Journal of the International AIDS Society|November 15, 2014
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA<50 cp/mLChiara Dentone, Daniela Fenoglio, Alessio Signori, et al.
The Journal of Allergy and Clinical Immunology|November 7, 2017
CD8<sup>+</sup>CD28<sup>-</sup>CD127<sup>lo</sup>CD39<sup>+</sup> regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection?Daniela Fenoglio, Chiara Dentone, Alessio Signori, et al.
Pageof 11